67041-1-Ig

antibody from Proteintech Group

Targeting: DNASE1L3 DNAS1L3, LSD

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

67041-1-Ig

Provider

Proteintech Group

Product name

DNASE1L3 antibody

Antibody type

Monoclonal

Description

DNASE1L3 antibody (Cat. #67041-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, mouse and has been validated for the following applications: IHC, WB, ELISA.

Reactivity

Human, Mouse

Host

Mouse

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

1A4D4

Vial size

20ul, 150ul

References

Submitted references

DNASE1L3 Mediates Hepatocellular Carcinoma Tumor Growth and Organoid Models via the Wnt/β-Catenin Signaling Pathway.

Zhang S, Zhao Y, Geng L, Song F, Feng L, Jiang J, Cai Q, Fan F
Oncology research 2026;34(3):27

---

Extrachromosomal DNA drives molecular and clinical heterogeneity in hepatocellular carcinoma: a multi-omics analysis and prognostic model development.

Huang K, Zhang G, Hu S, He Y, Zhai H, Xu J, Wang J, Hong S, Wu F, Shi X
Human genomics 2026 Feb 3;20(1)

---

Identification of DNASE1L3 as a novel biomarker of clinical stage in liver hepatocellular carcinoma.

Xue W, Xie S, Wu T, Li R, Lu D, Chen S, Xu Y, Wang Y
Frontiers in molecular biosciences 2025;12:1681888

---

Multi-omics analysis of polyamine metabolism implicates NT5E/CD73 in the progression of pancreatic cancer.

Zhang E, Ding X, Zhang J, Liu W, Liu G, Li M, Liu X, Wang Y, Zhang F, Li B, Zhu Y, Yan Y, Liu J, Wang Y, Tian X, Ma Y, Yang Y
Cancer letters 2025 Oct 10;630:217887

---

Prognostic implications and characterization of tumor-associated tertiary lymphoid structures genes in pancreatic cancer.

Zhang E, Ma Y, Liu Z, Zhang J, Liu W, Chen Y, Liu G, Liu X, Zhang F, Zhu Y, Yang Y, Tian X
Journal of translational medicine 2025 Mar 10;23(1):301

---

Deoxyribonuclease 1-like 3 may be a potential prognostic biomarker associated with immune infiltration in colon cancer.

Liu J, Yi J, Zhang Z, Cao D, Li L, Yao Y
Aging 2021 Jun 22;13(12):16513-16526